Geneos Wealth Management’s NEVRO CORP. NVRO Stock Holding History

Geneos Wealth Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-41	Closed	-$7K	–	3152
2021 Q1	$7K	Buy	+41	New	+$6.69K	﹤0.01%	2560
2019 Q1	–	Sell	-713	Closed	-$27K	–	2474
2018 Q4	$27K	Hold	713	–	–	﹤0.01%	1378
2018 Q3	$40K	Buy	+713	New	+$44.6K	﹤0.01%	1278
2018 Q2	–	Sell	-357	Closed	-$30K	–	2341
2018 Q1	$30K	Sell	357 -357	-50%	-$28.8K	﹤0.01%	1229
2017 Q4	$49K	Buy	+714	New	+$57.1K	﹤0.01%	1005
2017 Q3	–	Sell	-678	Closed	-$50K	–	2160
2017 Q2	$50K	Buy	+678	New	+$54.3K	0.01%	919

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geneos Wealth Management's NVRO Position: Q2 2021 in Review

Geneos Wealth Management sold out of NEVRO CORP. (NVRO) in Q2 2021, closing a stake of 41 shares — an estimated $7K sold.

Geneos Wealth Management first reported a position in NVRO in Q2 2017 and held it in 6 quarters. The position peaked at $50K in Q2 2017. 207 funds tracked by Wall St. Rank hold NVRO as of Q2 2021.

Geneos Wealth Management reported no remaining NEVRO CORP. position as of Q2 2021 after selling out during the quarter.
Geneos Wealth Management sold 41 NEVRO CORP. shares in Q2 2021, an estimated $7K.
Geneos Wealth Management first reported a position in NEVRO CORP. in Q2 2017 and held it in 6 quarters.
Geneos Wealth Management's NEVRO CORP. position peaked at $50K in Q2 2017.
207 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2021.

Based on Geneos Wealth Management's 13F filing for Q2 2021, filed 8 Jul 2021.